Comcast is in acquisition mode and rapidly embracing advanced technologies. But as it seeks new avenues for growth, will this multi-media colossus get stretched too thin? Read More
The following search results are from Investing Daily's public research only. Please Log In to search your premium services.
Results
We discuss the benefits of share repurchases and which companies recently made announcements to do so. Read More
Merck has been a money-making machine for decades, but it faces growing competition and patent expirations. Will this drug giant prevail? Read More
Believe it or not, this seemingly stodgy “old tech” copier company has delivered a 57% total return through the first 10 weeks of 2019. Read More
Home Depot is a DJIA component and steady dividend payer. But do economic headwinds and a cooling housing sector pose threats to this retail icon and its payout? Read More
Pfizer is a growth-and-income stock found in many retirement portfolios. But is the competition from biotech "disruptors" getting too hot for this Big Pharma stalwart? Read More
Chevron is poised to gain from rising crude prices, but the energy sector remains volatile. Can this "super major" overcome the industry's uncertainties? Read More
With FDA Chief Scott Gottlieb's departure, we're already seeing big price swings in stocks that may be affected by a change in FDA policy towards tobacco and health care companies. Read More
As the largest health insurer in the U.S., UnitedHealth Group is poised to greatly benefit from booming health care expenditures. But do proposed government policy changes threaten the stock? Read More
Many traders analyze stock charts to guide them in their trading decisions. We take a basic look at how understanding resistance and support levels can help a trader make money. Read More
Stock Talk Results
No Comments Found